Bilirubin has been shown to scavenge free radicals, normalize blood pressure in angiotensin II‐dependent hypertensive mice [38, 48] and prevent endothelial dysfunction by inhibiting the expression of inflammatory cytokines through the suppression of transcription factors such as NF‐kappaB [38, 49]. Here, NFKB1 is linked to endothelial dysfunction.